The use of PregVit in pregnancy.
Published: 2004
Language: eng
Number of pages: 118
Description: The objectives were to compare iron absorption between Materna RTM and PregVitRTM, to compare folate absorption between morning and at night and compare compliance and adverse events between PregVitRTM and MaternaRTM. Studies utilized a two-treatment, crossover design. For the iron kinetic study, twelve women randomly received 1 tablet of PregVitRTM a.m. or Materna RTM. Serum iron was measured over 8 hours. For the folate study, six women were randomly administered 1 multivitamin containing folic acid in the morning or evening. Finally, 138 pregnant women were randomly assigned either MaternaRTM or PregVitRTM for one month each to assess reported adverse events and compliance, which was done through pill counts and reports. The iron absorption was not significantly different between MaternaRTM and PregVitRTM. There was no circadian variation affecting folate absorption. PregVit RTM was associated with less constipation and had similar rates of compliance with MaternaRTM.
Notes: Adviser:  Gideon Koren.

Thesis (M.Sc.)--University of Toronto, 2004.

Electronic version licensed for access by U. of T. users.

Source: Masters Abstracts International, Volume: 43-03, page: 0830.

MICR copy on microfiche (2 microfiches).